Plegridy and Chronic obstructive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Chronic obstructive pulmonary disease is found among people who take Plegridy, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Plegridy and have Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 13,155 people who have side effects when taking Plegridy from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

13,155 people reported to have side effects when taking Plegridy.
Among them, 27 people (0.21%) have Chronic obstructive pulmonary disease.

What is Plegridy?

Plegridy has active ingredients of peginterferon beta-1a. eHealthMe is studying from 13,170 Plegridy users for its effectiveness, alternative drugs and more.

What is Chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 2,856 drugs and 2,088 conditions by eHealthMe.

Number of Plegridy and Chronic obstructive pulmonary disease reports submitted per year:

Could Plegridy cause Chronic obstructive pulmonary disease?

Time on Plegridy when people have Chronic obstructive pulmonary disease *:

Gender of people who have Chronic obstructive pulmonary disease when taking Plegridy *:

female: 77.78 %
male: 22.22 %

Age of people who have Chronic obstructive pulmonary disease when taking Plegridy *:

Common drugs people take besides Plegridy *:

Common side effects people have besides Chronic obstructive pulmonary disease *:

Pneumonia: 6 people, 22.22%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 14.81%
Abdominal Neoplasm (cancer of the stomach): 4 people, 14.81%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 3 people, 11.11%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 11.11%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 3 people, 11.11%
Nausea (feeling of having an urge to vomit): 3 people, 11.11%
Diarrhea: 3 people, 11.11%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 3 people, 11.11%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 7.41%

Common conditions people have *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 27 people, 100.00%
Stress And Anxiety: 3 people, 11.11%
Pain: 1 person, 3.70%
Hypersensitivity: 1 person, 3.70%
Gait Disturbance: 1 person, 3.70%
Asthma: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Plegridy and have Chronic obstructive pulmonary disease?

Check whether Chronic obstructive pulmonary disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Chronic obstructive pulmonary disease and when was it recovered:

Chronic obstructive pulmonary disease in Plegridy

Expand to all the drugs that have ingredients of peginterferon beta-1a:

Chronic obstructive pulmonary disease and drugs with ingredients of peginterferon beta-1a

Alternative drugs to, pros and cons of Plegridy:

Plegridy (13,170 reports)

Common Plegridy side effects:

Fatigue (feeling of tiredness): 819 reports
Pain: 684 reports
Headache (pain in head): 661 reports
Memory loss: 615 reports
Weakness: 599 reports
Fever: 573 reports

Browse all side effects of Plegridy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chronic obstructive pulmonary disease treatments and more:

Chronic obstructive pulmonary disease (180,051 reports)

COVID vaccines that are related to Chronic obstructive pulmonary disease:

Common drugs associated with Chronic obstructive pulmonary disease:

All the drugs that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,856 drugs)

Common conditions associated with Chronic obstructive pulmonary disease:

Rheumatoid arthritis: 3,895 reports
Osteoporosis: 3,472 reports
Asthma: 3,370 reports
High blood pressure: 3,274 reports

All the conditions that are associated with Chronic obstructive pulmonary disease:

Chronic obstructive pulmonary disease (2,088 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon beta-1a (the active ingredients of Plegridy) and Plegridy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.